Highlights
- Automating echocardiography with advanced AI technology.
- Raised €6M in funding to transform cardiac ultrasound analysis.
- Streamlining cardiologists’ workflows, enabling more focus on patient care.
About Ligence
Ligence, a health-tech startup from Lithuania, is redefining cardiac ultrasound analysis through artificial intelligence. By automating echocardiography, Ligence reduces the manual workload for cardiologists, freeing them to prioritise patient care and critical decision-making. Its AI tools integrate seamlessly with existing hospital systems and comply with international diagnostic standards for transparency and standardisation.
EIT and Investor Support
EIT Programs: Backed by EIT Climate-KIC, EIT Manufacturing, and EIT Urban Mobility.
Strategic Support: EIT initiatives have provided essential funding and mentorship to accelerate Ligence’s innovation and market reach.
Key Milestones
- Secured €6M in funding to advance AI-driven cardiac analysis.
- Built a team of 24 experts specialising in health-tech innovation.
- Established headquarters in Vilnius, Lithuania.
The Impact
Ligence’s cutting-edge AI technology significantly reduces the time and effort required for cardiac ultrasound analysis, improving diagnostic efficiency and enhancing patient care. By integrating seamlessly into hospital workflows, it ensures a smoother transition to AI-enhanced medical diagnostics, setting a new standard for precision in healthcare.